Creative Medical Technology (CELZ) announced mid-term follow-up data from its StemSpine pilot study utilizing its AlloStem cells for the ...

A new study led by researchers at Mass General Brigham suggests that different brain regions activated by creative tasks are part of one common brain circuit.

Validic, a leader in healthcare technology innovation, announces the launch of its patent-pending solution, a cutting-edge digital remote patient moni ...

Children's Hospital Los Angeles has opened its new Cardiac Imaging Suite, a 6,650-square-foot facility that will improve ...

A new study led by researchers at Mass General Brigham suggests that different brain regions activated by creative tasks are ...

Technology Holdings, Inc. (NASDAQ: CELZ), a biotechnology firm specializing in regenerative medicine with a market capitalization of approximately $7 million, has revealed promising one-year follow-up ...

Given these compelling results, Creative Medical Technology plans to advance the development of AlloStem (CELZ-201) for the treatment of late-stage Type 2 Diabetes and explore other potential ...

Creative Medical Technology (CELZ) announced one-year follow-up data from the AlloStem Type 2 Diabetes pilot study for late-stage patients.

A novel 3D bioprinted gastric cancer model using patient-derived tissues predicts drug responses, enhancing personalized ...

The University of Rochester Medical Center told News 8 it is “closely monitoring” NIH’s announcement it was cutting “indirect costs” for research institutions that receive its grants. According to the ...

Heart disease is the leading cause of death in the United States, and doctors suggest you might benefit from monitoring your ...

Fast forward to the nursing team Vento now leads on the fourth floor of Jacobs Medical Center. Compassionate care is at the ...